142 related articles for article (PubMed ID: 30664677)
1. Desmoid tumours stalled by sorafenib.
Wrighton KH
Nat Rev Clin Oncol; 2019 Apr; 16(4):209. PubMed ID: 30664677
[No Abstract] [Full Text] [Related]
2. Emerging Role of Multikinase Inhibitors in Desmoid Tumor Management.
Penel N; Ryckewaert T; Le Deley MC
Am J Clin Oncol; 2019 Dec; 42(12):958. PubMed ID: 31764064
[No Abstract] [Full Text] [Related]
3. Sorafenib for Advanced and Refractory Desmoid Tumors.
Gounder MM; Mahoney MR; Van Tine BA; Ravi V; Attia S; Deshpande HA; Gupta AA; Milhem MM; Conry RM; Movva S; Pishvaian MJ; Riedel RF; Sabagh T; Tap WD; Horvat N; Basch E; Schwartz LH; Maki RG; Agaram NP; Lefkowitz RA; Mazaheri Y; Yamashita R; Wright JJ; Dueck AC; Schwartz GK
N Engl J Med; 2018 Dec; 379(25):2417-2428. PubMed ID: 30575484
[TBL] [Abstract][Full Text] [Related]
4. Treatment of Orbital Desmoid-type Fibromatosis With Sorafenib.
Downie EM; Amend CE; Miranda A; Burkat CN
Ophthalmic Plast Reconstr Surg; 2022 Sep-Oct 01; 38(5):e144-e147. PubMed ID: 35470290
[TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging patterns of tumor response to chemotherapy in desmoid-type fibromatosis.
Zanchetta E; Ciniselli CM; Bardelli A; Colombo C; Stacchiotti S; Baldi GG; Provenzano S; Bertulli R; Bini F; Casale A; Greco FG; Ferrari A; Verderio P; Fiore M; Gronchi A; Casali PG; Morosi C; Palassini E
Cancer Med; 2021 Jul; 10(13):4356-4365. PubMed ID: 34102009
[TBL] [Abstract][Full Text] [Related]
6. Combination therapy with sorafenib and celecoxib for pediatric patients with desmoid tumor.
Robles J; Keskinyan VS; Thompson M; Davis JT; Mater DV
Pediatr Hematol Oncol; 2020 Aug; 37(5):445-449. PubMed ID: 32129687
[No Abstract] [Full Text] [Related]
7. Extra-abdominal aggressive fibromatosis treated with meloxicam and sorafenib: An encouraging option.
Sari M
J Cancer Res Ther; 2020; 16(4):900-902. PubMed ID: 32930137
[TBL] [Abstract][Full Text] [Related]
8. Autophagy inhibition overcomes sorafenib resistance in S45F-mutated desmoid tumors.
Braggio D; Koller D; Jin F; Siva N; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Strohecker AM; Lev D; Pollock RE
Cancer; 2019 Aug; 125(15):2693-2703. PubMed ID: 30980399
[TBL] [Abstract][Full Text] [Related]
9. Desmoid-type fibromatosis: toward a holistic management.
Penel N; Kasper B; van Der Graaf WTA
Curr Opin Oncol; 2021 Jul; 33(4):309-314. PubMed ID: 33973549
[TBL] [Abstract][Full Text] [Related]
10. [Magnetic resonance imaging of desmoid-type fibromatosis: Current evaluation criteria].
Ben Haj Amor M; Ploton L; Ceugnart L; Taïeb S
Bull Cancer; 2020 Mar; 107(3):359-363. PubMed ID: 32008700
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin-Eluting Intra-Arterial Therapy for Pediatric Extra-Abdominal Desmoid Fibromatoses: A Promising Approach for a Perplexing Disease.
Elnekave E; Atar E; Amar S; Bruckheimer E; Knizhnik M; Yaniv I; Dujovny T; Feinmesser M; Ash S
J Vasc Interv Radiol; 2018 Oct; 29(10):1376-1382. PubMed ID: 30075974
[TBL] [Abstract][Full Text] [Related]
12. Desmoid Tumors and Celecoxib with Sorafenib.
Benech N; Walter T; Saurin JC
N Engl J Med; 2017 Jun; 376(26):2595-2597. PubMed ID: 28657872
[No Abstract] [Full Text] [Related]
13. Desmoid tumors: who, when and how to treat?
Mikhael R; Smith M; Tzanis D; Watson S; Miah AB; Bonvalot S
Curr Opin Oncol; 2022 Jul; 34(4):335-341. PubMed ID: 35837705
[TBL] [Abstract][Full Text] [Related]
14. Complete Response to Sorafenib in Locally Recurrent Unresectable Aggressive Fibromatosis.
Burney IA; Kakaria AK; Al-Jahdhami S
Sultan Qaboos Univ Med J; 2021 May; 21(2):e327-e328. PubMed ID: 34221486
[No Abstract] [Full Text] [Related]
15. MRI diagnosis and follow-up of chest wall and breast desmoid tumours in patients with a history of oncologic breast surgery and silicone implants: A pictorial report.
Grubstein A; Rapson Y; Zer A; Gadiel I; Atar E; Morgenstern S; Gutman H
J Med Imaging Radiat Oncol; 2019 Feb; 63(1):47-53. PubMed ID: 30443994
[TBL] [Abstract][Full Text] [Related]
16. Active surveillance and emerging medical treatment options for desmoid: when and for whom?
Bonvalot S; Miah A; Kasper B
Curr Opin Oncol; 2024 Jul; 36(4):263-268. PubMed ID: 38726846
[TBL] [Abstract][Full Text] [Related]
17. A cost analysis of sorafenib for desmoid tumors.
Johns MS; Merritt WT; Rhodes L; Ford CN; Thompson M; Lee WM; Sheldon Y; Petrelli NJ; Tiesi GJ
J Oncol Pharm Pract; 2023 Apr; 29(3):663-668. PubMed ID: 35112974
[TBL] [Abstract][Full Text] [Related]
18. Aggressive and recurrent desmoid-type fibromatosis of the neck.
Monaco F; Monaco M; Barone M
Asian Cardiovasc Thorac Ann; 2015 Oct; 23(8):1002. PubMed ID: 24696104
[No Abstract] [Full Text] [Related]
19. Desmoid Tumors Respond to Sorafenib.
Cancer Discov; 2019 Mar; 9(3):313. PubMed ID: 30670460
[TBL] [Abstract][Full Text] [Related]
20. Staghorn sign: Extra-abdominal desmoid fibromatosis.
Ridley LJ; Han J; Ridley WE; Xiang H
J Med Imaging Radiat Oncol; 2018 Oct; 62 Suppl 1():157-158. PubMed ID: 30309161
[No Abstract] [Full Text] [Related]
[Next] [New Search]
